Literature DB >> 22349151

Psychotherapy use in a privately insured population of patients diagnosed with a mental disorder.

Ilan Harpaz-Rotem1, Daniel Libby, Robert A Rosenheck.   

Abstract

PURPOSE: Although there is growing evidence demonstrating the effectiveness of psychotherapy in the treatment of mental disorders, the use of psychotherapy in privately insured populations has not been examined. This study examines utilization rates and correlates of the receipt of psychotherapy.
METHODS: A large claims database of US private sector claims was used to examine utilization rates and correlates of receipt of psychotherapy. Altogether, 860,090 adults who received mental health services in 2005 were identified from the database. Multivariate binary regression and general linear models were used to assess the association of patient characteristics with use of psychotherapy, use of group or family therapy and the number of psychotherapy visits based on current procedural terminology (CPT) codes.
RESULTS: Only 32.4% of patients diagnosed with a mental illness received CPT codes indicating receipt of psychotherapy, and of these 96.5% received individual psychotherapy. Almost 75% of individuals diagnosed with posttraumatic stress disorder, 62% with major depressive disorder, and 54% with bipolar disorder received psychotherapy. Larger numbers of psychotherapy visits were associated with posttraumatic stress disorder (PTSD), alcohol use and mild depression. Larger numbers of psychotherapy visits were associated with PTSD, alcohol use and mild depression. Drug use, schizophrenia, bipolar disorder and major depressive disorder (MDD) were associated with fewer psychotherapy visits.
CONCLUSIONS: Substantial differences in use of psychotherapy were observed across diagnoses, perhaps reflecting the availability of alternative drug therapies. Greater use of psychotherapy in patients with PTSD may reflect weaker evidence of the effectiveness of pharmacological treatment, while less use in MDD may reflect greater evidence of drug benefits.

Entities:  

Mesh:

Year:  2012        PMID: 22349151     DOI: 10.1007/s00127-012-0486-9

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  37 in total

1.  The occupational transformation of the mental health system.

Authors:  Richard M Scheffler; Paul B Kirby
Journal:  Health Aff (Millwood)       Date:  2003 Sep-Oct       Impact factor: 6.301

2.  Factors associated with use of psychotherapy.

Authors:  Xavier Briffault; David Sapinho; Michael Villamaux; Viviane Kovess
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-11-26       Impact factor: 4.328

3.  Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.

Authors:  Ilan Harpaz-Rotem; Robert A Rosenheck; Somaia Mohamed; Rani A Desai
Journal:  Psychiatr Serv       Date:  2008-10       Impact factor: 3.084

Review 4.  The efficacy of psychodynamic psychotherapy.

Authors:  Jonathan Shedler
Journal:  Am Psychol       Date:  2010 Feb-Mar

5.  Psychotherapy in mental health clinics of the Department of Veterans Affairs.

Authors:  Marcia G Hunt; Robert A Rosenheck
Journal:  J Clin Psychol       Date:  2011-03-17

6.  Meta-analysis of psychotherapy outcome studies.

Authors:  M L Smith; G V Glass
Journal:  Am Psychol       Date:  1977-09

7.  Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.

Authors:  H A Pincus; T L Tanielian; S C Marcus; M Olfson; D A Zarin; J Thompson; J Magno Zito
Journal:  JAMA       Date:  1998-02-18       Impact factor: 56.272

8.  Psychotherapy in the Veterans Health Administration: Missed Opportunities?

Authors:  Jeffrey A Cully; Laura Tolpin; Louise Henderson; Daniel Jimenez; Mark E Kunik; Laura A Petersen
Journal:  Psychol Serv       Date:  2008-11

9.  Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.

Authors:  Kathleen M Carroll; Lisa R Fenton; Samuel A Ball; Charla Nich; Tami L Frankforter; Julia Shi; Bruce J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2004-03

Review 10.  Family treatment of child anxiety: outcomes, limitations and future directions.

Authors:  Cathy Creswell; Sam Cartwright-Hatton
Journal:  Clin Child Fam Psychol Rev       Date:  2007-09
View more
  7 in total

1.  Psychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders.

Authors:  Greta A Bushnell; Stacie B Dusetzina; Scott N Compton; Bradley N Gaynes; M Alan Brookhart; Til Stürmer
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-12-19       Impact factor: 2.576

2.  Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults With Dementia and Major Depressive Disorder.

Authors:  Sandipan Bhattacharjee; Jeannie K Lee; Asad E Patanwala; Nina Vadiei; Daniel C Malone; Shannon M Knapp; Wei-Hsuan Lo-Ciganic; William J Burke
Journal:  Am J Geriatr Psychiatry       Date:  2019-02-07       Impact factor: 4.105

3.  Rates and predictors of referral for individual psychotherapy, group psychotherapy, and medications among Iraq and Afghanistan veterans with PTSD.

Authors:  Juliette M Mott; Terri L Barrera; Caitlin Hernandez; David P Graham; Ellen J Teng
Journal:  J Behav Health Serv Res       Date:  2014-04       Impact factor: 1.505

4.  Predictors of non-drug psychiatric/psychotherapeutic treatment in children and adolescents with mental or behavioural disorders.

Authors:  Sascha Abbas; Peter Ihle; Jürgen-Bernhard Adler; Susanne Engel; Christian Günster; Martin Holtmann; Axel Kortevoss; Roland Linder; Werner Maier; Gerd Lehmkuhl; Ingrid Schubert
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-14       Impact factor: 4.785

5.  Psychotherapy for depression in primary care: a panel survey of general practitioners' opinion and prescribing practice.

Authors:  Hélène Verdoux; Sébastien Cortaredona; Hélène Dumesnil; Remy Sebbah; Pierre Verger
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-06-16       Impact factor: 4.328

6.  Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression.

Authors:  Rituparna Bhattacharya; Chan Shen; Amy B Wachholtz; Nilanjana Dwibedi; Usha Sambamoorthi
Journal:  BMC Psychiatry       Date:  2016-07-19       Impact factor: 3.630

7.  Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder.

Authors:  Sandipan Bhattacharjee; Jeannie K Lee; Nina Vadiei; Asad E Patanwala; Daniel C Malone; Shannon M Knapp; Wei-Hsuan Lo-Ciganic; William J Burke
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-08       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.